Abstract |
Cerebellar ataxia (CA) is a condition in which cerebellar dysfunction leads to movement disorders such as dysmetria, asynergy and dysdiadochokinesia. This study investigates the therapeutic effects of Melittin (MEL) on 3-acetylpyridine-induced (3-AP) cerebellar ataxia (CA) rat model. Initially, CA rat models were generated by 3-AP administration followed by the intraperitoneal injection of MEL. Then, motor performance and electromyography (EMG) activity were assessed. Afterwards, the pro-inflammatory cytokines were analyzed in the cerebellar tissue. Moreover, the anti-apoptotic role of MEL in CA and its relationship with the protection of Purkinje cells were explored. The findings showed that the administration of MEL in a 3-AP model of ataxia improved motor coordination (P < 0.001) and neuro-muscular activity (p < 0.05), prevented the cerebellar volume loss (P < 0.01), reduced the level of inflammatory cytokines (p < 0.05) and thwarted the degeneration of Purkinje cells against 3-AP toxicity (P < 0.001). Overall, the findings imply that the MEL attenuates the 3-AP-induced inflammatory response. As such, it could be used as a treatment option for CA due to its anti-inflammatory effects.
|
Authors | Zeynab Ghorbani, Mohammad Amin Abdollahifar, Kimia Vakili, Meysam Hassani Moghaddam, Mehdi Mehdizadeh, Hassan Marzban, Homa Rasoolijazi, Abbas Aliaghaei |
Journal | Toxicon : official journal of the International Society on Toxinology
(Toxicon)
Vol. 205
Pg. 57-66
(Jan 15 2022)
ISSN: 1879-3150 [Electronic] England |
PMID | 34793821
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 Elsevier Ltd. All rights reserved. |
Chemical References |
- Pyridines
- 3-acetylpyridine
- Melitten
|
Topics |
- Animals
- Apoptosis
- Cerebellar Ataxia
(chemically induced, drug therapy)
- Melitten
- Purkinje Cells
- Pyridines
- Rats
|